Network-based analysis of microRNAs targeting the RAS/MAPK signaling pathway in colorectal cancer

Sajjad Ataei Azimi ¹ , Elnaz Farzadifar ², Alireza Pasdar ³ , Forouzan Amerizadeh ^1,4 *

Cited by CrossRef: 2

1- Mia M, Datta B, Akter K, Das Topu T, Shawon J, Hossen F, Pranto A, Shadhin M, Tahsin N, Qahl S, Bakhsh T, Talukder M. Integrated Structural and Dynamic Analysis Reveals Destabilizing Effects of KRAS Missense Variants Associated with Lung Cancer. Protein J. 2026; [Crossref]

2- Naghinezhad J, Kamali Yazdi E, Mohajerian A, Yousefi Chermehini N, Ghanavati P, Motamedi H, Rezaeeyan H. The Tumor–Platelet–Immune Interface: Driving Metastasis, Pre-Metastatic Niche Formation and Therapeutic Vulnerabilities. Expert Rev Mol Med. 2026;28 [Crossref]

3- Kaikavoosnejad F, Haddad Kashani H, Dizaji Asl K, Mazloumi Z, Keyhani A, Ashraf Moosavi S, Verdi M, Rafat A. Targeting the PI3K/AKT/mTOR pathway in gastrointestinal cancers: a comprehensive review of mechanisms, preclinical evidence, and clinical challenges. Med Oncol. 2026;43(10) [Crossref]